Our Story
Cheri’s Promise to Her Grandmother
When I was five years old, my twin and I would go to visit my grandmother’s family in the nursing home. I remember the smell of urine was overwhelming. I would look in to the rooms as we passed through seeing all the older people wearing diapers. I thought to myself, “why are they wearing diapers and I am not?”
I remember tugging on my grandmother’s dress telling her, “One day, I am going to help these people.” She whispered in my ear, “Good, Honey. They are going to need it!”
To this day, I am fascinated by catheters and how they are made. Why do people need them and other medical devices that are used in the body? My grandmother has since passed away. When she passed, everyone released Monarch butterflies at her funeral. When I look at our logo, it reminds me of the promise I gave her.
Our Vision
Our Mission
Our mission is to liberate women from the embarrassment, insecurity, and cost of using sanitary paper products, external hand-held devices, or surgery, with our by-prescription–only, minimally-invasive, anti-microbial device for the treatment of stress urinary incontinence (SUI).
Milestones
2019
First Test
Test first subject in Houston, Texas.
2020
Clinical Research suspended due to Pandemic.
2021
New Product Redesign
2022
Receives IRB Approval for new clinical site.
2024
Early Feasibility Study
Complete Early Feasibility Study, design for manufacture, raise seed round, begin pivotal clinical trial.
2025
Complete pivotal Clinical Trial. Submit data to FDA and EMA. Hire sales, marketing, and clinical training teams. Train distributors’ sales forces. Educate and train doctors. Receive FDA and EMA clearance.
2026
First Year of Sales
Begin sales in four regional sales territories (2 US, 2 EU), reaching a market of 240 million women.
2027
Second Year of Sales
Second year of sales in four more regions.
2028
Third Year of Sales
Third year of sales in all of the US and European regions (12 regions).